ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable target Cancer Research UK to fully fund, sponsor, design, and execute CTA-enabling studies ...
Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON) (NASDAQ: BMM) is pleased to announce additional assay results from its ongoing 18,000 m relogging campaign, including the second ...
Belgian physicist Francis Halzen has won the 2026 Nobel Prize in Physics for his pioneering work on the IceCube Neutrino ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results